过多的因因于HFrEF中前向和后向失效的组合
Henrike Arfsten1, Gregor Heitzinger1, Suriya Prausmüller1
1Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
ESC heart failure
|March 9, 2024
概括
在心力衰竭中,排泄率降低,蛋白水平随着右心室功能恶化而上升,特别是在与减少 perfusion 结合时. 这一发现有助于解释患者的可变蛋白水平,并将其与较差的结果联系起来.
科学领域:
- 心脏病学 心脏病学
- 脏生理学 脏生理学
- 心脏衰竭病理生理学 病理生理学
背景情况:
- 氨酸-动脉素系统 (RAS) 在心力衰竭 (HF) 中起着至关重要的作用,但其在减少喷射分数 (HFrEF) 的HF中的调节仍然不清楚,许多患者表现出正常的氨酸水平.
- 实验模型表明,由左心室功能障碍引起的静脉堵塞可以减少 perfusion,并刺激蛋白分泌.
研究的目的:
- 研究HFrEF患者的右心室功能 (RVF) 和蛋白水平之间的关系.
- 确定其他因素,有助于提高RAS激活在这个群体.
主要方法:
- 这是一项针对332名慢性HFrEF患者的前性观察性研究.
- 收集了实验室参数 (蛋白,阿尔多斯特,NT-proBNP),心声回声和右心导管数据.
- 分析了蛋白水平与临床,血液动力学和心声学参数之间的关联.
主要成果:
- 素水平与NYHA类或NT-proBNP无关,但随着RVF参数 (例如FAC,TAPSE,TDI) 的恶化和 perfusion的减少而增加.
- 蛋白升高与减少的RVF与减少的 perfusion (P < 0.001) 相结合显著相关.
- 较高的宁水平与更差的生存结果相关.
结论:
- 在HFrEF中循环蛋白水平与RVF和 perfusion的严重程度有关,而不是传统的HF严重程度指数.
- 恶化RVF,特别是前后故障组件,有助于蛋白增加.
- 这种关系可以解释一些HFrEF患者的正常氨酸水平和血液动力学不良患者的升高水平.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
01:25Antihypertensive Drugs: Direct Renin Inhibitors
625
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
625
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
01:33Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K